Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
The overall goal of the Center for Skeletal Research is to foster Interdisciplinary and collaborative work that
leads to a deeper understanding of skeletal biology, in a way that can lead to new ways of diagnosing and
treating skeletal diseases. The Center will build upon and expand a community of bone scientists in the
Endocrine Unit and other Units at the Massachusetts General Hospital, the Harvard School of Dental
Medicine, and other Harvard-associated departments and institutions. This group has already defined itself
through a network of collaborations and a monthly seminar series sponsored jointly by the MGH Endocrine
Unit and the Harvard School of Dental Medicine, and includes bone scientists from multiple Harvard
institutions. These scientists are diverse, including clinical investigators and laboratory investigators using a
broad array of approaches from multiple disciplines. The mechanisms that the Center will use to accomplish
its goal include Core Facilities, a Pilot and Feasibility Grant Program, and a seminar series. The Cores will
include a Skeletal Phenotyping Core and a Bone Cells and Signaling Core. These Cores will emphasize the
development of new techniques that can drive the science of Center investigators, as well as the provision of
expert and efficient service. The goal of the Pilot and Feasibility Grant Program will be to allow young
investigators to develop sufficient data to obtain their own grants; in that context, a vigorous mentoring
program will complement the funding. The seminar series will foster collaboration and communication
among Center scientists. Young investigators will present current data in some sessions, while others will
bring in distinguished bone scientists from outside of Boston to enrich the environment. This series will also
include presentations by Core Directors that explain the techniques used in the Cores and will provide a
forum for feedback by Center investigators that will include suggestions for novel Core services. An
Administrative Core will assure effective functioning of these activities through regular meetings of Core
Directors that, four times a year, will also involve meeting with an Advisory Committee made up of senior
investigators within the Center, as well as investigators from elsewhere with relevant experience leading
similar programs. The Center will be committed to sharing its innovations with the broader community of
bone scientists across the country.
Public Health Relevance Statement
PUBLIC HEALTH RELEVANCE: This Center for Skeletal Research will further the discovery of the causes and therapies for skeletal diseases through the provision of core facilities and other programs designed to make the wok of a broad array of investigators more efficient, interdisciplinary, innovative and interactive. By making this research more effective, advances in understanding and therapy of osteoporosis and other bone disease will occur more quickly.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
073130411
UEI
FLJ7DQKLL226
Project Start Date
01-June-2014
Project End Date
31-May-2019
Budget Start Date
01-June-2016
Budget End Date
31-May-2017
Project Funding Information for 2016
Total Funding
$696,000
Direct Costs
$400,000
Indirect Costs
$296,000
Year
Funding IC
FY Total Cost by IC
2016
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$696,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P30AR066261-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30AR066261-03
Patents
No Patents information available for 5P30AR066261-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30AR066261-03
Clinical Studies
No Clinical Studies information available for 5P30AR066261-03
News and More
Related News Releases
No news release information available for 5P30AR066261-03
History
No Historical information available for 5P30AR066261-03
Similar Projects
No Similar Projects information available for 5P30AR066261-03